High-dose chemotherapy with hematopoietic stem-cell transplantation for breast cancer: current status, future trends

Clinical Breast Cancer
Filippo MontemurroRichard E Champlin

Abstract

High-dose chemotherapy with hematopoietic stem-cell transplantation (HDC/HSCT) has been extensively studied as a potential treatment for breast cancer. A literature search of MEDLINE from January 1990 through December 1999 identified 497 published full papers. Of these articles, 120 reported the results of clinical trials, 78 were reviews, and 299 reported on issues related to the technology of peripheral stem cells, supportive care, and toxicity. The phase II data must be interpreted with caution, as it is subject to selection bias; transplant recipients tended to be younger, rigorously staged, and selected to be chemotherapy responsive. There continues to be controversy regarding the role of high-dose therapy in this disease. Only a few fully published randomized trials are available; these studies were powered only to detect large differences in survival and no benefit was shown. Several large controlled trials are either in progress or are too early for definitive analysis. This review analyzes the current literature on HDC/HSCT for breast cancer, identifying prognostic factors and discussing ongoing research designed to improve antitumor effects.

References

Jul 5, 1992·The New England Journal of Medicine·R E CurtisR N Hoover
Feb 1, 1988·Journal of Surgical Oncology·F R AhmannT E Moon
Oct 1, 1980·The American Journal of Medicine·E Frei, G P Canellos
Jan 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M J Hjermstad, S Kaasa
Aug 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E van der WallS Rodenhuis
Oct 1, 1996·Immunology and Cell Biology·V ApostolopoulosG A Pietersz
Jan 1, 1997·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·D M HannK K Fields
Feb 14, 1998·Journal of the National Cancer Institute·J ZujewskiJ Abrams
Feb 26, 1998·American Journal of Respiratory and Critical Care Medicine·S W WilczynskiR J Folz
Jun 2, 1998·Cancer Treatment Reviews·T A Plunkett, D W Miles
May 27, 1999·Hematology and Cell Therapy·I McNieceE J Shpall
Aug 28, 1999·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·P A McSweeney, R Storb
Feb 3, 2000·Journal of the National Cancer Institute·G N HortobagyiR E Champlin
Feb 22, 2000·Lancet·B Farham, J Bradbury
Mar 21, 2000·Bone Marrow Transplantation·A M CarellaR Storb

❮ Previous
Next ❯

Citations

Jun 17, 2005·Expert Opinion on Pharmacotherapy·Filippo MontemurroMassimo Aglietta
Apr 24, 2002·Clinical Breast Cancer·P E Lønning
Jul 22, 2017·Expert Opinion on Biological Therapy·Susanna GalloFilippo Montemurro
Nov 7, 2002·European Journal of Nuclear Medicine and Molecular Imaging·Thomas M Behr

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
Antonia M S MüllerJudith A Shizuru
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
James M ReubenWendy A Woodward
© 2022 Meta ULC. All rights reserved